Binaltorphimine
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(1S,2S,7S,8R,12S,20R,24R,32R)-11,33-bis(cyclopropylmethyl)-22-methyl-19,25-dioxa-11,22,33-triazaundecacyclo[24.9.1.18,14.01,24.02,32.04,23.05,21.07,12.08,20.018,37.030,36]heptatriaconta-4(23),5(21),14(37),15,17,26(36),27,29-octaene-2,7,17,27-tetrol
|
|
Identifiers | |
CAS Number | 105618-27-7 |
ATC code | None |
PubChem | CID 5484197 |
ChemSpider | 24673307 |
ChEMBL | CHEMBL610001 |
Chemical data | |
Formula | C41H45N3O6 |
Molar mass | 675.813 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Binaltorphimine (BNI) is a selective antagonist of the κ-opioid receptor (KOR).[1] BNI and norbinaltorphimine (nor-BNI) were the first highly selective KOR antagonists to be discovered.[1]
See also[edit]
References[edit]
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |